Recurrent or prolonged mechanical circulatory support: bridge to recovery or road to nowhere?

Yves d'Udekem1, Nobuaki Shime, Song Lou

  • 1Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Australia. yves.dudekem@rch.org.au

Insights

For pediatric respiratory failure, extracorporeal membrane oxygenation (ECMO) offers prolonged support. However, for cardiac failure, ECMO beyond two weeks offers limited benefit, necessitating transition to ventricular assist devices or considering transplantation.

Area of Science:

  • Pediatric Critical Care Medicine
  • Cardiovascular Surgery
  • Mechanical Circulatory Support

Background:

  • Prolonged mechanical circulatory support (MCS) in children yields remarkable outcomes, yet futility thresholds remain unclear.
  • Extracorporeal membrane oxygenation (ECMO) survival for pediatric respiratory failure declines with support duration.
  • Cardiac failure management with MCS differs significantly from respiratory failure, with shorter effective support windows.

Purpose of the Study:

  • To delineate the optimal duration of extracorporeal membrane oxygenation (ECMO) in pediatric patients with cardiac versus respiratory failure.
  • To establish evidence-based guidelines for transitioning patients from ECMO to alternative mechanical circulatory support.
  • To evaluate the efficacy and outcomes of repeat ECMO interventions in pediatric patients.

Main Methods:

  • Review of clinical outcomes and survival data for pediatric patients undergoing prolonged mechanical circulatory support.
  • Analysis of extracorporeal membrane oxygenation (ECMO) duration in relation to patient diagnosis (respiratory vs. cardiac failure).
  • Evaluation of transition strategies to ventricular assist devices (VADs) and outcomes of repeat ECMO interventions.

Main Results:

  • Extracorporeal membrane oxygenation (ECMO) can support pediatric respiratory failure for extended periods (weeks to months) if managed without complications.
  • For pediatric cardiac failure, ECMO support beyond two weeks shows limited efficacy, with survival beyond 12 days in post-cardiac surgery patients being anecdotal.
  • Repeat ECMO offers minimal long-term benefit unless organ transplantation is pursued; transition to VADs is recommended after two weeks without recovery.

Conclusions:

  • Extracorporeal membrane oxygenation (ECMO) is viable for prolonged pediatric respiratory support but has a limited therapeutic window for cardiac failure.
  • Transitioning pediatric cardiac failure patients to ventricular assist devices (VADs) after two weeks of ECMO is critical for improved outcomes.
  • Repeat ECMO interventions in pediatric patients are generally not recommended due to poor long-term survival, except in the context of organ transplantation.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Restorative Care01:19

Restorative Care

Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...